FIM
PFE icon

Frontier Investment Management’s Pfizer PFE Stock Holding History

Frontier Investment Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$1.43M Buy
45,940
+4,376
+11% +$149K 0.09% 84
2020
Q1 		$1.29M Sell
41,564
-3,583
-8% -$122K 0.1% 76
2019
Q4 		$1.68M Sell
45,147
-1,380
-3% -$49.2K 0.1% 87
2019
Q3 		$1.59M Buy
46,527
+2,547
+6% +$92.6K 0.1% 84
2019
Q2 		$1.81M Buy
43,980
+4,439
+11% +$176K 0.12% 74
2019
Q1 		$1.59M Buy
39,541
+2,718
+7% +$109K 0.1% 97
2018
Q4 		$1.52M Buy
36,823
+2,403
+7% +$99.8K 0.11% 101
2018
Q3 		$1.44M Buy
34,420
+1,060
+3% +$40.8K 0.1% 109
2018
Q2 		$1.15M Sell
33,360
-865
-3% -$29.6K 0.09% 118
2018
Q1 		$1.15M Sell
34,225
-2,004
-6% -$68.9K 0.1% 111
2017
Q4 		$1.25M Sell
36,229
-524
-1% -$17.9K 0.1% 112
2017
Q3 		$1.25M Buy
36,753
+1,970
+6% +$63.3K 0.1% 110
2017
Q2 		$1.11M Buy
34,783
+188
+0.5% +$5.93K 0.1% 113
2017
Q1 		$1.08M Buy
34,595
+236
+0.7% +$7.44K 0.11% 99
2016
Q4 		$1.02M Buy
34,359
+533
+2% +$16.3K 0.1% 111
2016
Q3 		$10.9M Buy
33,826
+651
+2% +$21.8K 0.1% 103
2016
Q2 		$1.11M Sell
33,175
-717
-2% -$22.9K 0.14% 107
2016
Q1 		$891K Buy
33,892
+3,314
+11% +$94.7K 0.12% 101
2015
Q4 		$935K Sell
30,578
-918
-3% -$28.9K 0.15% 92
2015
Q3 		$912K Sell
31,496
-4,596
-13% -$147K 0.15% 94
2015
Q2 		$1.15M Buy
36,092
+1,773
+5% +$57.8K 0.13% 93
2015
Q1 		$1.1M Sell
34,319
-1,295
-4% -$41.2K 0.16% 90
2014
Q4 		$995K Buy
35,614
+2,175
+7% +$62.4K 0.17% 83
2014
Q3 		$938K Buy
33,439
+4,984
+18% +$140K 0.15% 87
2014
Q2 		$798K Sell
28,455
-3,511
-11% -$100K 0.13% 89
2014
Q1 		$834K Buy
31,966
+3,698
+13% +$110K 0.15% 86
2013
Q4 		$820K Buy
28,268
+3,566
+14% +$104K 0.15% 82
2013
Q3 		$673K Sell
24,702
-408
-2% -$11.1K 0.12% 86
2013
Q2 		$652K Buy
+25,110
New +$694K 0.13% 88

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Frontier Investment Management's PFE Position: Q2 2020 in Review

Frontier Investment Management increased its Pfizer (PFE) stake by 11% in Q2 2020, buying an estimated $149K and bringing the position to 45,940 shares worth $1.43M. The position accounts for 0.09% of the portfolio, ranked #84.

Frontier Investment Management first reported a position in PFE in Q2 2013 and has held it in 29 quarters since. The position peaked at $10.9M in Q3 2016. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.

  • Frontier Investment Management held 45,940 shares of Pfizer worth $1.43M as of Q2 2020.
  • Frontier Investment Management bought 4,376 Pfizer shares in Q2 2020, an estimated $149K.
  • Pfizer made up 0.09% of Frontier Investment Management's portfolio in Q2 2020, its #84 holding.
  • Frontier Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 29 quarters since.
  • Frontier Investment Management's Pfizer position peaked at $10.9M in Q3 2016.
  • 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.

Based on Frontier Investment Management's 13F filing for Q2 2020, filed 11 Aug 2020.